Matches in SemOpenAlex for { <https://semopenalex.org/work/W3106602607> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W3106602607 abstract "Abstract Background Sarcoidosis is a systemic inflammatory syndrome of unknown etiology and cardiac involvement has been reported to be an important prognostic factor in this disease. An autopsy study has reported that the frequency of this cardiac involvement (cardiac sarcoidosis: CS) varies in the different countries and races and very frequent in Japanese patients. We therefore performed the nationwide questionnaire survey and try to clarify the clinical characteristics and corticosteroid effect in CS, especially focused on arrhythmic events in this disease. Methods Total of 757 Japanese patients from 57 hospitals who diagnosed CS were examined. Patients who unsatisfied the criteria of the Japanese new guidelines, or who underwent cardiac transplantations were excluded, and 420 patients (287 females, median follow-up periods 1864 days [interquartile range: 845–3159 days]) were analyzed. The clinical outcome and corticosteroid effect were evaluated. Results Clinical characteristics at diagnosis was as follows: female dominant (68%), mean age of 60±13 years old, mean left ventricular ejection fraction was 49±16%. Arrhythmic events were very frequently observed as an initial cardiac manifestation in 263 patients (62%) of CS, of which atrioventricular block (AVB) in 174 (41%), ventricular tachycardia (VT) in 73 (17%) and AVB with VT in 17 (4%) (Figure 1A). Pacemaker was implanted in 166 patients (40%) and defibrillators was 137 patients (33%). Corticosteroid was prescribed in 144 (83%) of 174 patients with AVB and in 62 (85%) of 73 patients with VT. Initial dose was mean 47.9 mg and maintenance dose of mean 7.3 mg. Corticosteroid improved VT as good as AVB (27% vs. 29%). However, corticosteroid sometimes worsened VT events compared with AVB (10% vs. 2%) (Figure 1B). During the course of follow-up, 32 patients were needed to increase corticosteroid in 23 of AVB and 10 of VT cases. However, there were no difference in mortality between the groups, whether or not to increase corticosteroid. All survival rate was 92% (5-year mortality), 83% (10-year mortality) and free from all cause death and defibrillator charge was 81% (5 year), 71% (10 year). Conclusion Fatal arrhythmia is commonly observed in CS as a primary symptom. Corticosteroid sometimes worsen ventricular arrhythmia and appropriate defibrillator discharge was common. Thus, careful attention for activating ventricular arrhythmia would be needed during the follow-up period even after corticosteroid therapy. Funding Acknowledgement Type of funding source: None" @default.
- W3106602607 created "2020-12-07" @default.
- W3106602607 creator A5013007335 @default.
- W3106602607 creator A5016058595 @default.
- W3106602607 creator A5019042345 @default.
- W3106602607 creator A5024412870 @default.
- W3106602607 creator A5031042124 @default.
- W3106602607 creator A5048767065 @default.
- W3106602607 creator A5064721178 @default.
- W3106602607 creator A5064866359 @default.
- W3106602607 creator A5069484729 @default.
- W3106602607 creator A5071212973 @default.
- W3106602607 creator A5072149902 @default.
- W3106602607 creator A5073052770 @default.
- W3106602607 creator A5076149190 @default.
- W3106602607 creator A5077724157 @default.
- W3106602607 creator A5078962785 @default.
- W3106602607 date "2020-11-01" @default.
- W3106602607 modified "2023-10-16" @default.
- W3106602607 title "Long time clinical course of cardiac sarcoidosis with corticosteroid therapy -from Japanese nationwide questionnaire survey-" @default.
- W3106602607 doi "https://doi.org/10.1093/ehjci/ehaa946.2109" @default.
- W3106602607 hasPublicationYear "2020" @default.
- W3106602607 type Work @default.
- W3106602607 sameAs 3106602607 @default.
- W3106602607 citedByCount "0" @default.
- W3106602607 crossrefType "journal-article" @default.
- W3106602607 hasAuthorship W3106602607A5013007335 @default.
- W3106602607 hasAuthorship W3106602607A5016058595 @default.
- W3106602607 hasAuthorship W3106602607A5019042345 @default.
- W3106602607 hasAuthorship W3106602607A5024412870 @default.
- W3106602607 hasAuthorship W3106602607A5031042124 @default.
- W3106602607 hasAuthorship W3106602607A5048767065 @default.
- W3106602607 hasAuthorship W3106602607A5064721178 @default.
- W3106602607 hasAuthorship W3106602607A5064866359 @default.
- W3106602607 hasAuthorship W3106602607A5069484729 @default.
- W3106602607 hasAuthorship W3106602607A5071212973 @default.
- W3106602607 hasAuthorship W3106602607A5072149902 @default.
- W3106602607 hasAuthorship W3106602607A5073052770 @default.
- W3106602607 hasAuthorship W3106602607A5076149190 @default.
- W3106602607 hasAuthorship W3106602607A5077724157 @default.
- W3106602607 hasAuthorship W3106602607A5078962785 @default.
- W3106602607 hasBestOaLocation W31066026071 @default.
- W3106602607 hasConcept C119060515 @default.
- W3106602607 hasConcept C126322002 @default.
- W3106602607 hasConcept C137627325 @default.
- W3106602607 hasConcept C164705383 @default.
- W3106602607 hasConcept C187212893 @default.
- W3106602607 hasConcept C2776331378 @default.
- W3106602607 hasConcept C2776804153 @default.
- W3106602607 hasConcept C2778198053 @default.
- W3106602607 hasConcept C2778557577 @default.
- W3106602607 hasConcept C2781301800 @default.
- W3106602607 hasConcept C2911014034 @default.
- W3106602607 hasConcept C71924100 @default.
- W3106602607 hasConcept C78085059 @default.
- W3106602607 hasConceptScore W3106602607C119060515 @default.
- W3106602607 hasConceptScore W3106602607C126322002 @default.
- W3106602607 hasConceptScore W3106602607C137627325 @default.
- W3106602607 hasConceptScore W3106602607C164705383 @default.
- W3106602607 hasConceptScore W3106602607C187212893 @default.
- W3106602607 hasConceptScore W3106602607C2776331378 @default.
- W3106602607 hasConceptScore W3106602607C2776804153 @default.
- W3106602607 hasConceptScore W3106602607C2778198053 @default.
- W3106602607 hasConceptScore W3106602607C2778557577 @default.
- W3106602607 hasConceptScore W3106602607C2781301800 @default.
- W3106602607 hasConceptScore W3106602607C2911014034 @default.
- W3106602607 hasConceptScore W3106602607C71924100 @default.
- W3106602607 hasConceptScore W3106602607C78085059 @default.
- W3106602607 hasIssue "Supplement_2" @default.
- W3106602607 hasLocation W31066026071 @default.
- W3106602607 hasOpenAccess W3106602607 @default.
- W3106602607 hasPrimaryLocation W31066026071 @default.
- W3106602607 hasRelatedWork W1987882554 @default.
- W3106602607 hasRelatedWork W2002292227 @default.
- W3106602607 hasRelatedWork W2045718995 @default.
- W3106602607 hasRelatedWork W2150648742 @default.
- W3106602607 hasRelatedWork W2328249516 @default.
- W3106602607 hasRelatedWork W2416078561 @default.
- W3106602607 hasRelatedWork W2547306814 @default.
- W3106602607 hasRelatedWork W4318172591 @default.
- W3106602607 hasRelatedWork W4318384953 @default.
- W3106602607 hasRelatedWork W2091998127 @default.
- W3106602607 hasVolume "41" @default.
- W3106602607 isParatext "false" @default.
- W3106602607 isRetracted "false" @default.
- W3106602607 magId "3106602607" @default.
- W3106602607 workType "article" @default.